drugset
drugset / Trial / NCT00315601

Intrapulmonary Pharmacokinetics of Antibiotics

NCT00315601 ↗

Phase 4 Terminated 35 enrolled University of Illinois at Chicago Sanofi · collab
Non-randomizedCrossoverOpen-label

Summary

The major objectives of this research are to see how much, and for how long, telithromycin and azithromycin get into the fluids and cells of the lung.

Timeline

Start
2006-01
Primary completion
2006-11
Completion
2006-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule 250 mg Oral
Subject Telithromycin Small molecule 800 mg Oral

Indications

No indication recorded.